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Abstract
Background: Gestational diabetes (GDM) is a common complication of pregnancy. The impact of pregnancy
complications on placental function suggests that extraembryonic stem cells in the placenta may also be affected
during pregnancy. Neonatal tissue-derived stem cells, with the advantages of their differentiation capacity and non-
invasive isolation processes, have been proposed as a promising therapeutic avenue for GDM management
through potential cell therapy approaches. However, the influence of GDM on autologous stem cells remains
unclear. Thus, studies that provide comprehensive understanding of stem cells isolated from women with GDM are
essential to guide future clinical applications.
Methods: Human chorionic membrane-derived stem cells (CMSCs) were isolated from placentas of healthy and
GDM pregnancies. Transcriptional profiling was performed by DNA microarray, and differentially regulated genes
between GDM- and Healthy-CMSCs were used to analyse molecular functions, differentiation, and pathway
enrichment. Altered genes and biological functions were validated via real-time PCR and in vitro assays.
Results: GDM-CMSCs displayed, vs. Healthy-CMSCs, 162 upregulated genes associated with increased migration
ability, epithelial development, and growth factor-associated signal transduction while the 269 downregulated
genes were strongly linked to angiogenesis and cellular metabolic processes. Notably, significantly reduced
expression of detoxification enzymes belonging to the aldehyde dehydrogenase gene families (ALDH1A1/1A2,
ALDH2, ALDH3) accounted for downregulation across several metabolic pathways. ALDH activity and inhibitor
assays indicated that reduced gene expression of ALDHs affected ALDH enzymatic functions and resulted in
oxidative stress dysregulation in GDM-CMSCs.
Conclusion: Our combined transcriptional analysis and in vitro functional characterisation have provided novel
insights into fundamental biological differences in GDM- and Healthy-CMSCs. Enhanced mobility of GDM-CMSCs
may promote MSC migration toward injured sites; however, impaired cellular metabolic activity may negatively
affect any perceived benefit.
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Background
Mesenchymal stem cells (MSCs) are present in many
adult tissues and play a role in tissue regeneration and
maintenance. Their regenerative potential provides nu-
merous benefits for disease treatment [1]. In terms of dif-
ferentiation potential toward multiple lineages and their
inherent immunomodulatory capacity, MSC from differ-
ent tissues may share an element of a common transcrip-
tional signature [2]. However, transcriptional profiles have
also been shown to be unique for MSCs derived from dif-
ferent tissues [3–5]. Stem cell therapies remain hampered
by our incomplete knowledge of these fundamental differ-
ences [6]. Unlike embryonic stem cells, the MSC niche in
specific adult tissues may affect and determine the gene
expression in those specific tissue-derived MSCs [7]. It is
highly likely that many genes critical to regenerative func-
tions of MSCs or altered gene signatures associated with
different MSC sources are not understood. An improved
knowledge of MSC gene profiles would facilitate effective
strategies for the use of MSCs in regeneration medicine.
The placenta has a pivotal role in embryogenesis and
contains plentiful undifferentiated stem cells and as part of
the extraembryonic tissue, and stem cells can be isolated
from the placenta without additional invasive procedures or
additional ethical concerns [8]. During embryogenesis, the
extraembryonic mesoderm surrounding the amniotic cavity
gives rise to the placental membrane, composed of the am-
niotic and chorionic mesoderm [9]. Chorionic MSCs
(CMSCs) are derived from the chorion and share common
MSC characteristics and multipotency [10, 11]. As CMSCs
emerge during pregnancy, their characteristics are highly
likely to be affected by pregnancy complications. Gesta-
tional diabetes mellitus (GDM) is a common pregnancy
complication defined by the new onset of glucose intoler-
ance during pregnancy [12]. The hyperglycaemic environ-
ment leads to long-term adverse effects on the offspring
and the mother, including increased risk of GDM in subse-
quent pregnancies and type 2 diabetes in later life [13]. Pre-
vious studies have shown that maternal GDM had an
adverse effect on the proliferation and viability of umbilical
cord-derived MSCs [14], as well as low yield rate of perivas-
cular stem cells from umbilical cords [15]. Chorionic villus-
derived mesenchymal stromal cells exhibited decreased clo-
nogenicity and angiogenic potential in GDM compared
with healthy pregnancies [16]. However, the underlying
molecular events behind those observed differences remain
unclear.
A microarray study on umbilical vein endothelial cells
derived from GDM pregnancies indicated altered gene
expression in insulin sensing and extracellular matrix
reorganisation [17]. Gene profiles of umbilical cord
tissue from diabetic pregnancies showed alterations in
genes associated with vascular development and function
[18]. It is noticeable that very few studies have
investigated the MSC transcriptional signature altered by
pregnancy complications. Not only is gene profiling
research on the regenerative ability of MSCs from GDM
pregnancies limited, but microarray profiling of CMSCs
is yet to be described and made publically available.
With increasing interest in the utilisation of placental
MSCs and their banking for clinical purposes, under-
standing the characteristics and regenerative potential of
placental MSCs has become an important subject. Thus,
we sought to explore gene expression profiles between
CMSCs isolated from healthy and GDM placenta and es-
tablish biological differences or similarities. Our findings
demonstrate the influence of GDM on CMSC transcrip-
tional profiles with corresponding changes in functional-
ity through in vitro assays. The observed enhanced
migration and epithelial development potential in GDM-
CMSCs may have clinical benefits for wound healing.
On the other hand, the decreased expression and activity
of ALDH detoxification enzymes in GDM-CMSCs leads
to downregulation of several degradation pathways and
an impaired ability to respond to oxidative stress. The
comprehensive understanding of GDM-CMSCs reveals
the benefits and disadvantages of utilising CMSCs from
GDM pregnancies for future regenerative medicine.
Materials and methods
Human samples
Placenta samples were obtained with informed written
consent and in accordance with procedures approved by
the Research Ethics Committee and Health Research
Authority (Reference 15/WM/0342). Full-term placentas
from 10 healthy and 11 GDM pregnancies were col-
lected from Royal Stoke University Hospital, UK.
Cell isolation and culture
All placentas were collected immediately after caesarean
section, and cell isolation was performed within 1 h.
CMSCs were isolated from the chorionic membrane and
characterised by immunophenotyping with high levels of
expression of typical MSC markers CD73, CD90, and
CD105 and low levels of CD14, CD19, CD34, CD45, and
HLA-DR. CMSC isolation, as previously described [19],
was performed by removing the amniotic membrane
and decidual tissue from the chorionic membrane,
digesting with 0.05% trypsin/EDTA solution followed by
digestion media containing 1 mg/ml collagenase type IV
and 25 μg/ml DNase I (Thermo Scientific) in serum-free
Dulbecco’s modified Eagle medium (DMEM, Lonza).
Cells were cultured in DMEM consisting of 10% foetal
bovine, serum 1% L-glutamine, and 1% non-essential
amino acids (NEAA, Lonza). The CMSC samples used
in DNA microarray were from 3 healthy and 3 GDM
pregnancies at passage 3. Other samples were used for
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validation of microarray data by analysis gene expression
through qPCR and functional assays.
DNA microarray
0.2 μg of total RNA was amplified and labelled with Cy3
(CyDye, Agilent Technologies) for in vitro transcription
process. Labelled cRNA was pooled and hybridised to Agi-
lent SurePrint Microarray (Agilent Technologies) according
to the manufacturer’s protocol. Arrays were scanned with
an Agilent microarray scanner and images analysed by
Feature extraction10.7.3.1 software (Agilent Technologies).
Microarray analysis using bioinformatics software
Venn diagram and hierarchical clustering heat maps
were created by AltAnalyze software (Gladstone Institu-
tion, UCSF) and used to identify commonly upregulated
or downregulated genes and illustrate the differentially
expressed gene lists of interest.
Ingenuity Pathway Analysis (IPA, Qiagen; www.qiagen.
com/ingenuity) was used to analyse genes with fold
changes > 1.5 in GDM samples vs. healthy samples.
Overrepresented and underrepresented biological func-
tions and canonical pathways were identified based on
the selected genes using Ingenuity Knowledge Database
(Qiagen). The p value, calculated with the Fisher’s exact
test, indicates the likelihood that the association between
a set of genes in the experimental dataset and a bio-
logical function or pathway is the result of random
chance. The p value < 0.05 indicates a statistically signifi-
cant. z-score based on the match of target genes and
biological pathway/function; expression changes of these
target genes and their agreement with literature finding
predicted the up/downregulation patterns.
Pathway network visualisation was created by Cytoscape
v.3.6.1. Enriched gene sets identified by IPA pathway ana-
lysis were selected and used as input nodes. The interaction
network was generated according to literature findings and
public database. The network was manually curated and
distributed with circles for easier visualisation.
RNA extraction and real-time PCR
Total RNA were isolated at passage 3, using TRIzol
Reagent (Invitrogen) according to the manufacturer’s in-
struction. Reverse transcription was performed with High-
Capacity cDNA Reverse Transcription Kit (Thermo Scien-
tific). Gene expression analysis was evaluated by real-time
PCR using QuantiFast SYBR Green PCR Kit (Qiagen). Pri-
mer sequences are shown in Table 1. The relative
Table 1 Primer sequences
Genes Forward sequence Reverse sequence
CD24 CTCCTACCCACGCAGATTTATTC AGAGTGAGACCACGAAGAGAC
AQP1 CTGCATGGTCAAGCCTCTTA TCAAGGGAGTGGGTGAATTG
FLNB TGATCTATGTGCGCTTCGGT GACATGCATTTACCGGTGCC
CELSR1 TACTTCTGCGGTGCTGGTTT GTCCGTAAACCGTCCCTTCC
EDN1 CCATGAGAAACAGCGTCAAATC CGAAGGTCTGTCACCAATGT
HBEGF AATCTGGCTTAGTGCCACCC GCACTCTGACCACGGAAGAT
TGFB2 ATGCGGCCTATTGCTTTAGA ACCCTTTGGGTTCGTGTATC
CTCF GCCTGTTCCAAGACCTGTG GGCGGCTCTGCTTCTCTA
NKX2.5 CAACATGACCCTGAGTCCCC TAATCGCCGCCACAAACTCT
NOG CATGCCGAGCGAGATCAAA CAGCCACATCTGTAACTTCCTC
PDGFA GGAACGCACCGAGGAAGA GCCAGGAGGAGGAGAAACAG
NPPB TGGAAACGTCCGGGTTACAG GACTTCCAGACACCTGTGGG
MET TGGTGCAGAGGAGCAATGG CATTCTGGATGGGTGTTTCCG
CXCL12 ATGAACGCCAAGGTCG GGGCTACAATCTGAAGGG
RASIP1 CGTCTCCTTGAGAACCAATACC CATTCCACGCGGGATAAGAA
RSPO3 CACCTTTATCTGAGCCAATGGA ATGCAGGGGGATCTGACATA
HMOX1 TCTTGGCTGGCTTCCTTACC GGATGTGCTTTTCGTTGGGG
ALDH1A1 TCAAACCAGCAGAGCAAACT TAGGCCCATAACCAGGAACA
ALDH2 CTGCTGACCGTGGTTACTT CTCCCAACAACCTCCTCTATG
ALDH3B1 GCTGAAGCCATCGGAGATTAG GCTCCCTGTGAAGAAGATGTAG
NQO1 GGGATGAGACACCACTGTATTT AGTGATGGCCCACAGAAAG
SOD2 GGACAAACCTCAGCCCTAAC GCCGTCAGCTTCTCCTTAAA
GAPDH ACTTCAACAGCACACCCACT GCCAAATTCGTTGTCATACCAG
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expression levels of mRNA were normalised to GAPDH,
and fold change was calculated using the 2^-(ΔΔCt)
method.
Transwell migration assay
Cells were placed onto the upper chamber of a Trans-
well filter with 8-μm pores (Corning), and the bottom
well contained regular growth media culturing in a 37 °C
incubator. After 8 and 24 h, migrated cells were fixed
with methanol and stained with crystal violet. Migration
was quantified by cell counts in five separate fields per
sample and expressed as mean numbers. Data represent
6 independent experiments in each group, performed in
triplicate.
Wound healing assay
5 × 105 cells were seeded into each well of a 6-well plate
and cultured for 2 days. Wounds were created by
scratching with a 200-μl pipette tip, and media were
changed to remove suspension cells. After incubating for
12 h, cells were visualised under a light microscope.
Relative cell migration was calculated by measuring the
final wound area compared to the initial area. Three
non-overlapping fields were picked and examined per
well. Data represent 6 independent experiments in each
group.
ALDH activity analysis
ALDH function was measured by aldehyde dehydrogen-
ase activity colorimetric assay kit (Sigma). Acetaldehyde
is oxidised by ALDH generating NADH which reacts
with a probe and the activity of ALDH measured by ab-
sorbance reading at 450 nm. Cells were lysed by ALDH
buffer and manufacturer’s protocol followed. Absorb-
ance was measured every 5 min over a 30-min period.
The activity of ALDH was calculated according to the
manufacturer’s suggestion. All samples were performed
in triplicate.
Detection of intracellular ROS
ROS was detected by 2′,7′-dichlorofluorescin diacetate
(DCFDA, also known as H2DCFDA) cellular reactive
oxygen species detection kit (Abcam). Cells were seeded
at 10,000 cells/well in a 96-well plate. After attachment,
cells were incubated with 25 μM DCFDA for 45 min at
37 °C and then treated with 5mM or 25mM glucose.
For fluorescent images, ROS detection was observed by
a confocal microscope. Images were taken from ran-
domly chosen fields in each experiment. The intensity of
fluorescence was measured by a microplate reader, and
the signal was read at excitation/emission: 485/535 nm.
A blank well containing no cells (media only) was used
as a background signal. All samples were performed in
triplicate.
Statistics
All statistics were calculated by GraphPad Prism 6 soft-
ware. Student’s t test was used to compare paired or un-
paired data. Values are presented as mean ± SEM, and
p < 0.05 is determined as significant: *p < 0.05, **p < 0.01,
and ***p < 0.001.
Results
Identification of differentially expressed genes and
biological function analysis
Gene expression profiles of CMSCs derived from 3
healthy (H-CMSCs) and 3 GDM women (GDM-CMSCs)
were determined by DNA microarray analysis. Valid-
ation of microarray results was performed with 10 H-
CMSCs and 11 GDM-CMSCs samples. Applying a cut-
off of p < 0.05 and 1.5-fold change between H-CMSCs
and GDM-CMSCs, we identified a total of 431 differen-
tially expressed genes (DEGs), including 162 upregulated
and 269 downregulated genes in all 3 GDM samples
(Fig. 1a). The 3 GDM women were treated for their
GDM with either metformin (GDM6), insulin (GDM7),
or both (GDM8). The sample from the women who
received both metformin and insulin treatment exhibited
the highest number of total DEGs.
Biological function analysis using DEGs identified in
all 3 GDM-CMSCs samples was performed with Ingenu-
ity Pathway Analysis (IPA) focussed on two categories:
“molecular and cellular functions” and “physiological
system development and functions”. Applying a cut-off
of average -log(p value) > 30 using Fisher’s exact test, the
most represented “molecular and cellular functions” in
GDM-CMSCs were related to cell death and survival,
cellular growth and proliferation, and cellular movement
(Fig. 1b). To further identify the altered downstream cel-
lular process of the most represented biological func-
tions, the activation z-score computed by IPA was used
to infer the activation/inhibition state and gene enrich-
ment. A positive z-score indicates increased functional
activity in GDM-CMSCs relative to H-CMSCs while a
negative z-score indicates a reduction in activity. Posi-
tively associated cellular processes in GDM-CMSCs
included cell survival, viability, cellular migration and
movement, assembly and organisation of cytoskeleton,
and skin formation, which are critical functions in
wound repair and tissue remodelling (Fig. 1c). DEGs in
GDM-CMSCs associated with the positively regulated
cellular processes were displayed by gene clustering heat
maps, indicating the upregulated expression levels and
increased wound healing and remodelling potential
(Fig. 1d). Noticeably, organismal death was the most
downregulated cellular process in GDM-CMSCs while
other negatively associated functions including stimula-
tion of cells, homing, and colony formation showed less
significant z-score values (Fig. 1c).
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Fig. 1 (See legend on next page.)
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Differentially expressed genes in GDM-CMSCs are
significantly involved in cardiovascular system
development
In terms of the tissue regenerative potential of GDM-
CMSCs, the most represented biological function in the
“physiological system development” category was cardiovas-
cular system development and function, which had an aver-
age -log(p value) > 30 (Fig. 1e). Further in-depth analysis of
the downstream functional activation performed in relation
to cardiovascular system development showed that cardio-
genesis was the most significantly overrepresented down-
stream cellular process with the highest positive z-score,
along with the positive association with development of
cardiovascular tissue (Fig. 1f). The heat map illustrated a set
of genes involved in cardiogenesis that were highly
expressed in GDM-CMSCs compared to H-CMSCs, sug-
gesting the greater potential of GDM-CMSCs in cardiac
regeneration (Fig. 1g). In contrast, the cellular processes of
vasculogenesis and angiogenesis in cardiovascular develop-
ment had decreased activation with negative z-scores
(Fig. 1f). The heat map showed the downregulation of vas-
culogenesis and vasculature development-associated genes
in GDM-CMSCs compared with H-CMSCs (Fig. 1g).
Moreover, other enriched downstream cellular processes in
the “physiological system development” category included
respiratory system development and formation of the lung
and kidney with a positive z-score while development of
the exocrine gland and connective tissue had negative z-
scores in GDM-CMSCs (Additional file 1: Figure S1).
Validation of increased migration ability, wound healing
potential, and cardiac development in GDM-CMSCs
To evaluate functional differences between H-CMSCs
and GDM-CMSCs, elevated expression of genes involved
in migration, survival, and cellular assembly ability in
GDM-CMSCs were validated through real-time PCR
and migration assays. DEGs associated with cell migra-
tion (CD24, AQP1), cellular assembly (FLNB, CELSR1),
and skin formation and healing process (EDN1, HBEGF,
TGFB2, CTGF) were significantly upregulated in GDM-
CMSCs compared to H-CMSCs (Fig. 2a and Add-
itional file 2: Figure S2a). Transwell migration was
performed to examine cell motility, where H-/GDM-
CMSCs were placed into the upper compartment of a
Transwell filter and allowed to migrate through the filter
for 8 and 24 h. After either 8 or 24 h of incubation, en-
hanced migration ability was observed in GDM-CMSCs
with a greater number of cells having migrated across
the membrane (Fig. 2b, c). In wound healing assays,
higher numbers of GDM-CMSCs migrated into the
wound field at every observed time point (6, 12, 24 h)
than H-CMSCs. The closure percentages were signifi-
cantly increased, with approximately 30% in GDM-
CMSCs and 20% in H-CMSCs after 12 h (Fig. 2d and
Additional file 3: Figure S3). Collectively, both the
Transwell migration and wound healing assay validated
the enhanced migration ability in GDM-CMSCs.
Cardiovascular development was identified as the most
enriched biological function in GDM-CMSCs with al-
tered gene expression in cardiogenesis and vasculogen-
esis. The expression of genes associated with
cardiogenesis (NKX2.5, NOG, PDGFA, NPPB, MET)
showed significant increases in GDM-CMSCs vs. H-
CMSCs (Fig. 2e and Additional file 2: Figure S2b). The
opposite trend was found in vasculogenesis-associated
genes, which showed a significantly reduced expression
of RASIP1, CXCL12, RSPO3, and HMOX1 in GDM-
CMSCs (Fig. 2f and Additional file 2: Figure S2b). Taken
together, CMSCs derived from GDM placenta may
therefore have better potential application in wound
repair and cardiogenesis than in vasculogenesis when
compared to H-CMSCs.
Pathways mediating cardiac development and cell
movement are both upregulated in GDM-CMSCs
Gene regulatory networks were examined incorporating
DEGs for positively regulated (Fig. 3a) and negatively
regulated pathways (Fig. 3b). The STAT3 pathway, with
roles in development, cellular homeostasis, cell growth,
proliferation, and differentiation [20], was the most sig-
nificantly upregulated signalling pathway in GDM-
CMSCs with the highest ratio and -log(p value). The ac-
tivation of pathways such as BMP signalling, Wnt/β-ca-
tenin signalling, and FGF signalling which were
(See figure on previous page.)
Fig. 1 Identification of DEGs and enriched biological functions in GDM-CMSCs. a Venn diagram indicates the numbers of genes up- or
downregulated > 1.5-fold in GDM-CMSCs vs. Healthy-CMSCs. The overlapping areas of the 3 circles are co-regulated genes and defined as
differentially expressed genes (DEGs). b Biological functions in “molecular and cellular functions” category were generated and ranked by IPA
analysis. Bars indicate overrepresented functions in GDM-CMSCs compared to H-CMSCs. Individual GDM-MSC samples are represented via specific
indicated colours. c Activation state of enriched downstream cellular processes in “molecular and cellular functions” using IPA activation z-score
identification of increased (positive z-score) or decreased activity (negative z-score) in GDM-CMSCs compared to Healthy-CMSCs. d Heat maps of
DEGs involved in cell survival and growth, cellular movement and assembly, skin formation, and epithelial development. Expression levels are
represented by log2 fold change (expression value in each sample vs. mean expression value in Healthy-CMSCs). Expression levels range from
high (red) to low (green). e Biological functions in “physiological system development and function” category in GDM-CMSCs identified by IPA. f
Cellular processes associated with “cardiovascular system development and function” in GDM-CMSCs. The activation state was calculated by IPA
activation z-score. g Heat maps summarised DEGs involved in cardiogenesis and vasculogenesis
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upregulated in GDM-CMSCs may transduce through
STAT3 signalling and contribute to the regulation of
various development processes. Multiple upregulated
genes in GDM-CMSCs were involved in BMP, Wnt/
β-catenin, and FGF signalling (Fig. 3c). Additionally,
BMP, Wnt/β-catenin, and FGF signalling play an
important role in heart development. As the cardiac-
associated genes, NKX2.5 and NOG, are regulated
downstream to BMP, Wnt/β-catenin, and FGF path-
ways, the previously observed upregulation of NKX2.5
and NOG in GDM-CMSCs may contribute to en-
hanced cardiogenesis potential via the modulation of
Fig. 2 Validation of gene expression and altered biological functions in GDM-CMSCs through real-time PCR and in vitro migration assays. a
Upregulation in genes associated with cell migration/cellular assembly (CD24, FLNB, AQP1) and wound healing (EDN1, HBEGF) in GDM-CMSCs
validated by real-time PCR with 10 Healthy- and 11 GDM-CMSCs samples. Gene expression levels were normalised to GAPDH and presented as
fold change by comparing G-CMSCs to H-CMSCs using 2^-(ΔΔCt) method. b Motility of cell was evaluated by Transwell migration assay.
Representative images of migrated Healthy-CMSCs and GDM-CMSCs stained with crystal violet after 8 and 24 h of migration period. Scale bar
150 μm. c Cell migration ability was calculated by counting migrated cells per field by ImageJ. Data represent 6 independent experiments in
triplicate. d The graph indicates wound closure percentages, and the images below are representative images of wound healing assay. Healthy-
CMSCs and GDM-CMSCs migrated into the middle wound field after 12 h. The percentage of wound closure was calculated by measuring the
reduced wound area after 6 h and 12 h by ImageJ. Data were obtained from 6 independent experiments. Scale bar 150 μm. e Significant
upregulation of cardiogenic genes in GDM-CMSCs. Validation of NKX2.5, NOG, and PDGFA expression in healthy and GDM samples was examined
by real-time PCR. The expression level of each gene was normalised to GAPDH. f Significant downregulation of vasculogenic genes in GDM-
CMSCs. RASIP1, CXCL12, and RSPO3 expressions were validated by real-time PCR. The expression level of each gene was normalised to GAPDH. All
error bars in this figure are presented as mean ± SEM. Student’s t test was used for statistical significance, *p < 0.05, **p < 0.01, ***p < 0.001
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Fig. 3 (See legend on next page.)
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the BMP, Wnt/β-catenin, and FGF pathways. Other regu-
latory factors, such as WNT3/11, LEF1, and FZD in the
Wnt/β-catenin signalling pathway and FGF1, MAPK, and
MET in the FGF signalling pathway, also displayed higher
expression in GDM-CMSCs than in H-CMSCs (Fig. 3c).
Moreover, the increased activity of Rho family GTPase
signalling in GDM-CMSCs, including Rac, RhoA, and
Cdc42 signalling, associates with the regulation of cell
migration, invasion, and cytoskeleton organisation [21].
The clustering map showed an increased expression of
genes involved in Rho family signalling in GDM-
CMSCs, suggesting that enhanced cell movement cap-
acity in GDM-CMSCs may be associated with activation
through Rho family signalling (Fig. 3d). Nuclear receptor
signalling via LPS/IL-1-mediated inhibition of RXR func-
tion pathway also showed an increased activity in GDM-
CMSCs.
Significantly reduced expression in ALDH family genes
results in a negative association with metabolic pathways
in GDM-CMSCs
Among the downregulated metabolic pathways, most
were associated with degradation processes, including
ethanol degradation, oxidative ethanol degradation, and
fatty acid α-oxidation as well as the degradation of neu-
rotransmitters (histamine, dopamine, noradrenaline,
serotonin) and other molecules (putrescine, tryptophan)
(Fig. 3b). Given the dysfunctional metabolic regulation
in women with GDM, these pathways are of particular
interest for investigating GDM-CMSCs behaviours. Fig-
ure 3e illustrates the genes associated with these
enriched downregulated pathways and showed that the
decreased activities of degradation pathways were con-
nected to the significant reduction in aldehyde dehydro-
genase family gene expression, ALDH1, ALDH2, and
ALDH3 (Fig. 3e). Aldehydes can be formed during the
metabolism of amino acids, carbohydrates, lipids, and vi-
tamins as well as cytotoxic drugs and environmental
chemicals [22]. ALDH genes encode the key enzymes
that regulate cellular detoxification through oxidation of
endogenous and exogenous aldehydes, and play an im-
portant role in many degradation processes [23]. Not-
ably, ALDH1A1 is one of the most downregulated genes
in GDM-CMSCs (Table 2). Other genes including
ALDH1A2, ALDH2, and ALDH3B1 were also signifi-
cantly reduced in GDM-CMSCs microarray data and
comprised the core molecules of the downregulated
pathway network. The deficiency of ALDH family genes
may lead to insufficient detoxification resulting in alde-
hyde accumulation and reactive oxygen species (ROS)
imbalance. Additionally, a critical pathway for ROS regu-
lation, the Nrf2-mediated oxidative stress response path-
way, showed downregulation in GDM-CMSCs, owing to
the low expression of important regulators, protein kin-
ase (PRKC), and antioxidant enzyme genes (HMOX1,
SOD2, AOX1) (Fig. 3f).
Other downregulated pathways, such as “IL-6 signal-
ling” and “HGF signalling”, regulate multiple molecules
involved in angiogenesis (Fig. 3b). For instance, CEBPB,
(See figure on previous page.)
Fig. 3 Positively and negatively regulated pathway analysis and regulatory network visualisation. a, b IPA canonical pathway analysis of positively
and negatively regulated pathways in GDM-CMSCs. The x-axis indicates the altered canonical pathways in GDM-CMSCs. The left y-axis indicates
the statistical significance p value, calculated using Fisher’s exact test. The right y-axis represents the ratio of the number of dataset genes that
map to all known pathway genes. c, d Positively regulated canonical pathways and associated genes. Hierarchical clustering maps indicate the
expression of genes involved in BMP, Wnt/β-catenin, FGF signalling, and Rho family signalling. From left to right on the clustering maps are
presenting as GDM6, GDM7, and GDM8 samples. Each gene is normalised to a mean expression of 3 Healthy-CMSCs samples. Blue and red
indicate below and above mean expression, respectively, with values indicating log2 fold change. e, f Negatively regulated canonical pathways
and associated genes. Interaction networks were generated by Cytoscape visualisation based on DEGs. Hierarchical clustering map showed a
significant reduction in ALDH family gene expression in GDM-CMSCs and regulators of the Nrf2 pathway
Table 2 Top 10 upregulated and downregulated genes in
GDM-CMSCs vs. Healthy-CMSCs
Top 10 downregulated genes Average log2 ratio
PRKCB − 5.566
GJA8 − 4.166
CXCL12 − 3.436
FAM20A − 3.379
ALDH1A1 − 3.315
PRRX2 − 3.227
ATP8B4 − 3.040
RSPO3 − 2.927
CXCL3 − 2.925
CXCL1 − 2.914
Top 10 upregulated genes Average log2 ratio
RPS4Y1 9.873
COL17A1 9.344
DDX3Y 8.528
CDH1 8.376
KRT5 8.308
SCEL 8.207
SPRR3 7.823
PLD5 7.293
HAPLN1 7.102
L1TD1 6.996
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FOS, ELK1, and CXCL8 in angiogenesis pathways dis-
played low expression in GDM-CMSCs. Moreover, the
downregulation of “PI3K/AKT signalling” may affect the
potent angiogenic factors, IL-6, IL-8, HGF, and VEGF
signalling transduction through mediation of the PI3K/
AKT pathway to promote angiogenesis [24–26]. Bio-
logical function analysis identified downregulated genes
in angiogenesis and vasculogenesis as downstream com-
ponents of IL-6, IL-8, and HGF pathways suggesting a
regulatory network of reduced angiogenic potential in
GDM-CMSCs.
Reduced ALDH activity in GDM-CMSCs is associated with
reactive oxygen species dysregulation
Given that the decreased expression of ALDH family
genes affected several metabolic pathways and the nega-
tive activation of Nrf2-mediated oxidative stress regula-
tion, GDM-CMSCs are likely to have imbalanced
cellular ROS regulation as reflected in increased oxida-
tive stress which are found in diabetic tissues [27]. The
expression of ALDH1A1, ALDH2, and ALDH3B1 in
GDM-CMSCs and H-CMSCs was validated with real-
time PCR and demonstrated significantly reduced ex-
pression levels in GDM-CMSCs (Fig. 4a–c). We further
evaluated ALDH enzymatic function by ALDH colori-
metric activity assay using acetaldehyde as a substrate.
In the initial 5 min, there was no statistical difference in
ALDH activity between two groups but significantly
lower levels of ALDH activity in GDM-CMSCs were ob-
served at 10, 15, 20, and 25 min vs. H-CMSCs. The
ALDH activity gradually declined after 25 min in both
H-CMSCs and GDM-CMSCs. Of note, the highest level
of ALDH activity was seen at 15 min post-stimulation,
in H-CMSCs (Fig. 4d).
With impaired ALDH activity, the accumulation of
highly reactive and toxic aldehyde tends to induce ROS
formation and increase oxidative stress [28]. Antioxidant
defence reduces the harmful effects of ROS; however, a
significant reduction of antioxidative enzymes, including
NQO1 and SOD2 in GDM-CMSCs (Fig. 4e), suggested a
deficiency in their antioxidant systems. To examine ROS
production, H-CMSCs and GDM-CMSCs were stimu-
lated with glucose to induce metabolic activity. Follow-
ing the stimulation, ROS was produced in both H-
CMSCs and GDM-CMSCs while GDM-CMSCs were
observed to have higher levels of cellular ROS than H-
CMSCs after 2-h glucose treatment (Fig. 4f). Measuring
ROS production over a period of time, the ROS levels
increased, at comparable levels, for the first 45 min in
both H-CMSCs and GDM-CMSCs following stimulating
with glucose. Between 45 and 90min, ROS levels
showed significantly higher rates of increase in GDM-
CMSCs than in H-CMSCs. Notably, H-CMSCs did not
produce increased amounts of ROS after 90 min and
showed slightly reduced ROS generation whereas ROS
levels in GDM-CMSCs continued to increase and
remained elevated (Fig. 4g).
To further elucidate the influence of ALDH activity on
ROS regulation, the enzymatic function of ALDHs was
suppressed by N,N-diethylaminobenzaldehyde (DEAB), a
commonly used selective inhibitor of ALDHs. In the
presence of the ALDH inhibitor, the ALDH activity was
significantly suppressed in both H-CMSCs and GDM-
CMSCs (Fig. 4h). Moreover, when the ALDH function
was suppressed, the ROS production was significantly
increased during glucose-induced metabolic process
(Fig. 4i). DEAB pre-treated H-/GDM-CMSCs produced
higher levels of ROS than un-treated H-/GDM-CMSCs.
The finding confirmed the strong association between
the ALDH function and cellular ROS regulation.
Low levels of ROS are detectable in many metabolic
processes; however, when ROS production is in excess
of the cellular antioxidant capacity, it contributes to cel-
lular damage. We found that downregulation of Nrf2-
mediated oxidative stress regulation pathway and the
impaired function of detoxifying enzymes ALDHs re-
sulted in an insufficient capacity to respond to increased
oxidative stress in GDM-CMSCs.
Discussion
DNA microarray data provides an understanding of gene
profiles and biological functions altered in GDM-
CMSCs offering a valuable resource to regenerative
medicine development. To conclude from our findings,
the uterine environment during pregnancy could impact
on the biology of stem cells derived from perinatal tis-
sues. GDM-CMSCs, compared to H-CMSCs, displayed
an enhanced migration ability and a transcriptional pro-
file indicating potential in epithelial development and
skin formation and a putative role in wound repair. In
contrast, ALDH detoxification enzymes were signifi-
cantly reduced in GDM-CSMCs leading to downregula-
tion of several degradation pathways. Decreased ALDH
activity in GDM-CMSCs was also associated with an
impaired ability to respond to oxidative stress. Taken to-
gether, these novel findings derived from microarray and
associated functional assays can be useful for exploring
suitable clinical uses of CMSCs from GDM and healthy
pregnancies.
GDM-CMSCs had a number of upregulated genes in-
volved in cell motility, cytoskeleton organisation, sur-
vival, epithelial development, and skin formation. The
ability of transplanted cells to mobilise and migrate to
injury sites would enable a direct role in tissue repair
and regeneration [29]. A recent study suggested that
high glucose treatment increased human umbilical cord-
derived MSC motility and promoted the migration of
transplanted MSCs into mouse model wound site [30].
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Fig. 4 (See legend on next page.)
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Human umbilical endothelial cells isolated from GDM
pregnancies have also shown an increased migration
ability potentially reflecting a proangiogenic GDM state
[31]. In contrast, reduced wound closure capacity of
perivascular stem cells from GDM women [15] and im-
paired migration of GDM umbilical cord-derived endo-
thelial cells have also been reported [32]. Cell-specific
impacts of GDM on motility cannot be ruled out at this
time. Here we have demonstrated that GDM-CMSCs
display upregulated expression of AQP1, FLNB, CELSR1,
and CD24, which have important roles in cell movement
and cytoskeletal remodelling, and that the GDM-MSCs
have enhanced motility.
Dehydrated placental membrane has been used as a
skin substitute for burned and ulcerated surfaces for
many years [33, 34] while the presence of MSCs in cryo-
preserved placental membranes is further described as
improving wound-healing therapies [35, 36]. We identi-
fied the upregulation of epithelial development-
associated genes and regulators (EDN1, KRT14, HBEGF,
TGFB2) in GDM-CMSCs, which may be beneficial for
the clinical use as skin substitutes. The downregulation
of vasculogenic factors (RASIP1, CXCL12, RSPO3) and
the decreased activation of angiogenesis inducing path-
ways (IL-6, IL-8) were observed in GDM-CMSCs. It is
noteworthy that hypervascularisation is frequently ob-
served in GDM placentas due to hyperinsulinemia-
mediated accelerated foetal metabolism and oxygen up-
take, which leads to an imbalance in oxygen supply and
demand resulting in hypoxia-induced angiogenesis [37].
Although it would be sensible to assume the involve-
ment of GDM-CMSCs in hypervascularisation, CMSCs
derived from GDM placenta did not show an increase in
vasculogenesis-associated gene expression or angiogen-
esis pathway activity, suggesting that CMSCs may not
contribute to placental hypervascularisation in GDM.
On the contrary, immunohistochemistry staining of in-
creased VEGF protein in cytotrophoblast and syncytio-
trophoblast cells of GDM chronic villi [38, 39], flow
cytometry identifying elevated levels of VEGF receptors
on endothelial progenitor cells from GDM women [40],
and increased cytokine production from Hofbauer and
placental cells [41] were all associated with enhanced
angiogenesis and vasculogenesis in GDM. Various cell
types in GDM placenta contribute to hypervascularisa-
tion while reduced angiogenic ability in GDM-CMSCs
might represent a compensatory response to counteract
dysregulated angiogenesis and vascularisation or be im-
plicated in vascular function defects of GDM placenta.
In line with a recent study, a decreased in vitro tube for-
mation ability accompanied with bFGF and VEGF down-
regulation was observed in GDM chorionic villus-
derived MSCs [16]. Despite the high degree of angiogen-
esis under the hyperglycaemic environment, MSCs from
GDM placenta displayed a weak angiogenic potential.
This finding also pointed out the differential effects of
GDM on different placental cell types during pregnancy.
Pathways associated with several degradation processes
were altered in GDM-CMSCs largely due to the signifi-
cant reduction of ALDHs expression. As a critical de-
toxification enzyme, ALDHs are highly expressed in
multiple embryonic tissues, stem cells, and progenitor
cells [42, 43] and protect cells against oxidative damage
through detoxifying exogenous and endogenous alde-
hyde [28]. ALDH activity has also been used as an indi-
cator for purification of a proangiogenic BM-MSC
subset with enhanced secretory functions for vascular re-
generation [44]. Significantly reduced ALDH family
genes in GDM-CMSCs emphasised the adverse impacts
of the pregnancy complication on cellular detoxification.
GDM-CMSCs showed significantly lower ALDH enzym-
atic activity than H-CMSCs, which provided insufficient
capacity to manage increased oxidative stress caused by
hyperglycaemia. Upon stimulation, ROS production was
elevated to a greater extent in GDM-CMSCs than in H-
CMSCs with no sign of reduction, indicating the im-
paired cellular ROS regulation in GDM-CMSCs. The vi-
cious circle of increased oxidative stress and decreased
antioxidant defence progresses with gestation in GDM
pathology [45, 46]. A recent study showed that treating
decidual MSCs derived from preeclampsia women with
an ALDH1A1 activator restored ALDH1A1 activity and
improved H2O2-induced oxidative stress resistance in
preeclampsia-derived MSCs [47]. The physiologically
(See figure on previous page.)
Fig. 4 Decreased ALDH activity and increased cellular ROS level in GDM-CMSCs. a–c Expressions of ALDH1A1, ALDH2, and ALDH3B1 were
validated by real-time PCR with 10 Healthy- and 11 GDM-CMSCs samples. Gene expression levels were normalised to GAPDH and presented as
fold change by comparing G-CMSCs to H-CMSCs using the 2^-(ΔΔCt) method. d ALDH activity colorimetric assay of ALDH enzymatic function in
Healthy- and GDM-CMSCs. Results obtained from 6 independent experiments in duplicate. GDM-CMSCs showed reduced ALDH activity compared
to Healthy-CMSCs. e Real-time PCR of Nrf2-mediated oxidative stress pathway genes; NQO1 and SOD2 were significantly reduced in GDM-CMSCs.
Gene expression levels were normalised to GAPDH. f ROS production determined by DCFDA staining (green). Representative fluorescent images
of the ROS level are shown from 3 independent experiments at different time points and imaged by confocal microscopy. Scale bar 100 μm. g
Time-course measurement of ROS production measured by fluorescent intensity. The initial fluorescence intensity at 0 min was set at 100%.
Results obtained from 6 independent experiments in triplicate. h, i H-CMSCs and GDM-CMSCs ALDH function inhibited by 100mM DEAB. ALDH
enzymatic functions were examined and ROS generation evaluated by DCFDA fluorescent intensity. All error bars in this figure are presented as
mean ± SEM. Student’s t test was used for statistical significance, *p < 0.05, **p < 0.01, ***p < 0.001
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harmful environment of oxidative stress in GDM may be
improved by antioxidant intake [48, 49]; however, restor-
ing ALDH function itself would be a viable therapeutic
target of GDM.
Developing therapeutic strategies using autologous
MSCs requires a thorough understanding of their bio-
logical characteristics in vitro and in vivo. Although
GDM animal models present multiple challenges due to
their temporary disease condition and complex inducing
factors, several studies have investigated biological prop-
erties of MSCs under type I and II diabetes mouse
models. For instance, bone marrow MSCs derived from
non-obese diabetic mice were found to produce high
levels of proinflammatory cytokines, including IL-1α/β
and MCP-1 [50]; streptozotocin-induced diabetic mice
showed a reduced number of MSCs and increased apop-
tosis tendency [51]; and one study reported altered tri-
lineage differentiation ability in bone marrow- and
adipose-derived MSCs from high-fat diet-induced obese
mice [52]. Various effects of diabetes on MSCs were
reported over the years but the lack of comprehensive
understanding impedes the development of autologous
cell therapy. Moreover, relatively little is known about
placenta-derived MSCs from GDM pregnancy. Our
study provides a thorough analysis of genetic profiles of
CMSCs from GDM and healthy women, and ultimately,
in vitro functionality will require in vivo evaluation and
large participation numbers to further elucidate thera-
peutic potential.
Conclusion
In summary, the progression of regenerative medicine and
advanced cell banking technology provides an option for
the use of perinatal tissue-derived autologous MSCs for
personalised medicine. The effect of GDM on CMSC gene
expression was evidenced by DNA microarray analysis
coupled to functional assay identification of associated
impaired and enhanced functions in GDM-MSCs. These
data will assist in the identification and development of
suitable applications of GDM-CMSCs and eventually
transform the knowledge into clinical practice.
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